Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05445427 · ClinicalTrials.gov registry record · NA

Vagal Nerve Stimulation for Post COVID Fatigue

A NA study of Fatigue and Headache, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
18
Enrollment target
1
Study location

NCT05445427 is a NA study of Fatigue and Headache that has completed, run by Mayo Clinic. The registered enrollment target is 18 participants, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05445427, a NA study of Fatigue and Headache, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
18 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.

Interventions

  • DEVICE vagal nerve stimulator

Study Locations (1)

Minnesota

  • Mayo Clinic in Rochester - Rochester

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2022-12-21
Est. Completion 2024-03-28
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05445427

The ClinicalTrials.gov registry entry for NCT05445427 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 218-participant average among 109 other Fatigue trials with a reported enrollment target (92% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Fatigue appearing as the primary indexed condition, and to 1 intervention - of which vagal nerve stimulator is the first listed.

NCT05445427 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05445427 about?

NCT05445427 is a clinical study titled "Vagal Nerve Stimulation for Post COVID Fatigue". The purpose of this study is to evaluate the impact of vagal nerve stimulation on patients with post COVID syndrome who have fatigue and headache.

What is the current status of trial NCT05445427?

This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2022-12-21. Estimated completion is 2024-03-28.

What conditions does trial NCT05445427 study?

This clinical trial studies the following conditions: Fatigue, Headache, Post COVID Syndrome.

What interventions are being tested in trial NCT05445427?

The interventions under investigation include: vagal nerve stimulator (DEVICE).

Who is sponsoring clinical trial NCT05445427?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05445427 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Fatigue

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.